IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model

International Archives of Allergy and Immunology

Volumn 145, Issue 2, 2008, Pages 152-162

  Van Overtvelt, Laurence ^a   Lombardi, Vincent ^a   Razafindratsita, Alain ^a   Saint Lu, Nathalie ^a   Horiot, Stéphane ^a   Moussu, Hélène ^a   Mascarell, Laurent ^a   Moingeon, Philippe ^a  

^a Stallergenes SA   (France)

Author keywords

1,25 Dihydroxyvitamin D3; Adjuvants; Allergy vaccines; Dendritic cells; Glucocorticoids; Lactobacillus; Regulatory T cells; Sublingual immunotherapy

Indexed keywords

CALCITRIOL; CALCITRIOL PLUS DEXAMETHASONE; DEXAMETHASONE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; OVALBUMIN; PROBIOTIC AGENT; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CD4+ T LYMPHOCYTE; CELL MATURATION; CERVICAL LYMPH NODE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; LACTOBACILLUS PLANTARUM; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SUBLINGUAL IMMUNOTHERAPY; TH1 CELL; TREATMENT RESPONSE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, SUBLINGUAL; ANIMALS; ASTHMA; CALCITRIOL; CELLS, CULTURED; DENDRITIC CELLS; DESENSITIZATION, IMMUNOLOGIC; DEXAMETHASONE; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; INTERLEUKIN-10; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; OVALBUMIN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 36749096949     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108140     Document Type: Article

References (51)

1. Benjaponpitak S, Oro A, Maguire P, Marinkovich V, DeKruyff RH, Umetsu DT: The kinetics of change in cytokine production by CD4 T cells during conventional allergen immunotherapy. J Allergy Clin Immunol 1999;103:468-475.
2. De Wit D, Amraoui Z, Vincart B, Michel O, Michils A, Van Overvelt L, Willems F, Goldman M: Helper T-cell responses elicited by Der p 1-pulsed dendritic cells and recombinant IL-12 in atopic and healthy subjects. J Allergy Clin Immunol 2000;105:346-352.
3. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, Kay AB, Hamid QA: Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferongamma. J Allergy Clin Immunol 1996;97:1356-1365.
4. Ebner C, Siemann U, Bohle B, Willheim M, Wiedermann U, Schenk S, Klotz F, Ebner H, Kraft D, Scheiner O: Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin Exp Allergy 1997;27:1007-1015.
5. Mavroleon G: Restoration of cytokine imbalance by immunotherapy. Clin Exp Allergy 1998;28:917-920.
6. Francis JN, Till SJ, Durham SR: Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003;111:1255-1261.
7. Jutel M, Akdis M, Budak F, Ebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis CA: IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003;33:1205-1214.
8. Mamessier E, Birnbaum J, Dupuy P, Vervloet D, Magnan A: Ultra-rush venom immunotherapy induces differential T cell activation and regulatory patterns according to the severity of allergy. Clin Exp Allergy 2006;36:704-713.
9. Till SJ, Francis JN, Nouri-Aria K, Durham SR: Mechanisms of immunotherapy. J Allergy Clin Immunol 2004;113:1025-1034.
10. Ciprandi G, Fenoglio D, Cirillo I, Vizzaccaro A, Ferrera A, Tosca MA, Puppo F: Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report. Ann Allergy Asthma Immunol 2005;95:38-44.
11. Cosmi L, Santarlasci V, Angeli R, Liotta F, Maggi L, Frosali F, Rossi O, Falagiani P, Riva G, Romagnani S, Annunziato F, Maggi E: Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production. Clin Exp Allergy 2006;36: 261-272.
12. Romagnani S: Regulatory T cells: which role in the pathogenesis and treatment of allergic disorders? Allergy 2006;61:3-14.
13. Savolainen J, Jacobsen L, Valovirta E: Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC. Allergy 2006;61:1184-1190.
14. Jonuleit H, Schmitt E: The regulatory T cell family: distinct subsets and their interrelations. J Immunol 2003;171:6323-6327.
15. Taylor A, Verhagen J, Blaser K, Akdis M, Akdis CA: Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology 2006;117:433-442.
16. Schleimer RP, Derse CP, Friedman B, Gillis S, Plaut M, Lichtenstein LM, MacGlashan DW Jr: Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. J Immunol 1989;143:1310-1317.
17. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K: Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998;102:98-106.
18. Akdis CA, Blaser K, Akdis M: Mechanisms of allergen-specific immunotherapy. Chem Immunol Allergy 2006;91:195-203.
19. Stock P, DeKruyff RH, Umetsu DT: Inhibition of the allergic response by regulatory T cells. Curr Opin Allergy Clin Immunol 2006;6:12-16.
20. Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van OL: Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 2006;61:151-165.
21. Allam JP, Novak N, Fuchs C, Asen S, Berge S, Appel T, Geiger E, Kochan JP, Bieber T: Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive FcεRI expression. J Allergy Clin Immunol 2003;112:141-148.
22. Novak N, Allam JP, Betten H, Haberstok J, Bieber T: The role of antigen presenting cells at distinct anatomic sites: they accelerate and they slow down allergies. Allergy 2004;59:5-14.
23. Novak N: Targeting dendritic cells in allergen immunotherapy. Immunol Allergy Clin North Am 2006;26:307-319, viii.
24. Murphy KM, Heimberger AB, Loh DY: Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 1990;250:1720-1723.
25. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B, Niederwieser D, Schuler G: Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 1996;196:137-151.
26. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992;176:1693-1702.
27. Razafindratsita A, Saint-Lu N, Mascarell L, Berjont N, Bardon T, Betbeder D, Van Overtvelt L, Moingeon P: Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation. J Allergy Clin Immunol 2007;120:278-285.
28. Kline JN, Kitagaki K, Businga TR, Jain VV: Treatment of established asthma in a murine model using CpG oligodeoxynucleotides. Am J Physiol Lung Cell Mol Physiol 2002;283:L170-L179.
29. Larche M, Akdis CA, Valenta R: Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006;6:761-771.
30. Hawrylowicz CM, O'Garra A: Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005;5:271-283.
31. Crameri R, Rhyner C: Novel vaccines and adjuvants for allergen-specific immunotherapy. Curr Opin Immunol 2006;18:761-768.
32. Jutel M, Akdis M, Blaser K, Akdis CA: Mechanisms of allergen specific immunotherapy - T-cell tolerance and more. Allergy 2006;61:796-807.
33. Wing K, Sakaguchi S: Regulatory T cells as potential immunotherapy in allergy. Curr Opin Allergy Clin Immunol 2006;6:482-488.
34. Drakes M, Blanchard T, Czinn S: Bacterial probiotic modulation of dendritic cells. Infect Immun 2004;72:3299-3309.
35. 3. Immunol Lett 2004;91:63-69.
36. Wilckens T, De RR: Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today 1997;18:418-424.
37. Adorini L, Penna G, Giarratana N, Roncari A, Amuchastegui S, Daniel KC, Uskokovic M: Dendritic cells as key targets for immunomodulation by vitamin D receptor ligands. J Steroid Biochem Mol Biol 2004;89-90:437-441.
38. 3 analogs as immunomodulatory agents. Trends Mol Med 2002;8:174-179.
39. Adorini L: 1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation. Curr Opin Investig Drugs 2002;3:1458-1463.
40. Adorini L: Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol 2002;2:1017-1028.
41. Pujols L, Mullol J, Torrego A, Picado C: Glucocorticoid receptors in human airways. Allergy 2004;59:1042-1052.
42. Penna G, Roncari A, Amuchastegui S, Daniel KC, Berti E, Colonna M, Adorini L: Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 2005;106:3490-3497.
43. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002;195:603-616.
44. Sun JB, Cuburu N, Blomquist M, Li BL, Czerkinsky C, Holmgren J: Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions. Scand J Immunol 2006;64:251-259.
45. Boyle RJ, Tang ML: The role of probiotics in the management of allergic disease. Clin Exp Allergy 2006;36:568-576.
46. Vaarala O: Immunological effects of probiotics with special reference to lactobacilli. Clin Exp Allergy 2003;33:1634-1640.
47. Daniel C, Repa A, Wild C, Pollak A, Pot B, Breiteneder H, Wiedermann U, Mercenier A: Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy 2006;61:812-819.
48. Repa A, Grangette C, Daniel C, Hochreiter R, Hoffmann-Sommergruber K, Thalhamer J, Kraft D, Breiteneder H, Mercenier A, Wiedermann U: Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 2003;22:87-95.
49. Charng YC, Lin CC, Hsu CH: Inhibition of allergen-induced airway inflammation and hyperreactivity by recombinant lactic-acid bacteria. Vaccine 2006;24:5931-5936.
50. Grangette C, Nutten S, Palumbo E, Morath S, Hermann C, Dewulf J, Pot B, Hartung T, Hols P, Mercenier A: Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci USA 2005;102:10321-10326.
51. Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Capel TM, Zaat BA, Yazdanbakhsh M, Wierenga EA, van Kooyk Y, Kapsenberg ML: Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005;115:1260-1267.